Genomma Lab Internacional, S.A.B. de C.V (LABB.MX) Return on Equity (ROE)

Price: $24.86
Market Cap: $24.86B
Avg Volume: 3.27M
Country: MX
Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Beta: 0.525
52W Range: $13.9-29.18
Website: Genomma Lab Internacional, S.A.B. de C.V

Return on Equity (ROE) Summary

Genomma Lab Internacional, S.A.B. de C.V's ROE measures the return generated on shareholders' equity:

  • Annual: 18.44%
  • Quarterly: 4.09%
  • TTM: 19.84%

What is Return on Equity (ROE)?

Return on Equity measures a company's ability to generate profits from its shareholders' equity. It indicates how effectively the management is using the company’s assets to create profits. A higher ROE generally reflects well on the company’s management and its ability to generate profits without needing as much capital.

Related Metrics

Other important metrics to assess Genomma Lab Internacional, S.A.B. de C.V's profitability include:

  • ROIC (Return on Invested Capital) - measures how effectively the company uses its invested capital to generate profits:
    • Annual: 16.99%
    • Quarterly: 4.62%
    • TTM: 16.99%
  • ROA (Return on Assets) - measures the return generated on the company's assets:
    • Annual: 8.87%
    • Quarterly: 1.97%
    • TTM: 8.87%
  • Profit Margin - indicates the profitability of the company relative to its revenue:
    • Annual: 11.49%
    • Quarterly: 10.15%
    • TTM: 11.49%

These metrics provide insights into Genomma Lab Internacional, S.A.B. de C.V's profitability and efficiency in using its capital and assets to generate returns. Comparing these ratios with industry benchmarks can offer a deeper understanding of the company's performance.

Annual ROE

18.44%

Quarterly ROE

4.09%

TTM ROE

19.84%

Genomma Lab Internacional, S.A.B. de C.V Historical ROE
18.68%18.68%9.84%9.84%0.99%0.99%-7.85%-7.85%-16.70%-16.70%-25.54%-25.54%ROE20162016201720172018201820192019202020202021202120222022202320232024202420252025
Historical ROIC
23.24%23.24%16.99%16.99%10.74%10.74%4.50%4.50%-1.75%-1.75%-7.99%-7.99%-14.24%-14.24%ROIC20162016201720172018201820192019202020202021202120222022202320232024202420252025
Historical ROA
8.87%8.87%4.96%4.96%1.04%1.04%-2.87%-2.87%-6.79%-6.79%-10.70%-10.70%ROA20162016201720172018201820192019202020202021202120222022202320232024202420252025

Genomma Lab Internacional, S.A.B. de C.V Historical Profitability Metrics

The table below shows various profitability metrics for each year, with the latest data available for the last fiscal year 2024.

Year ROE ROIC ROA Profit Margin
2024 18.44% 16.99% 8.87% 11.49%
2023 11.49% 12.75% 5.23% 6.59%
2022 13.68% 11.68% 6.43% 8.26%
2021 12.98% 10.50% 6.07% 8.44%
2020 14.57% 10.38% 6.34% 10.12%
2019 9.59% 7.54% 3.97% 6.01%
2018 14.94% 10.15% 6.14% 9.41%
2017 18.68% 13.06% 8.05% 10.59%
2016 -25.54% -14.24% -10.70% -14.85%
2015 -11.89% -4.68% -6.06% -9.68%

Related Metrics

Explore detailed financial metrics and analysis for LABB.MX.